Brazilian Controlled Drugs and Substances Act

CBSA seizes over 30 kg of suspected narcotics at Coutts border crossing

Retrieved on: 
Tuesday, May 2, 2023
Seizure, Narcotic, Methamphetamine, The Royal Canadian Mounted Police in Quebec, AB, Customs Act 1967, Canada Border Services Agency, Purpose, Controlled Substances Act, CBSA, Cocaine, Public security, Opium, Prohibition of drugs, Brazilian Controlled Drugs and Substances Act, Controlled substance, RCMP, Safety, Drug

On April 9, 2023, CBSA officers discovered and seized approximately 30 kg of suspected cocaine following the examination of a commercial truck at the Coutts border crossing in southern Alberta.

Key Points: 
  • On April 9, 2023, CBSA officers discovered and seized approximately 30 kg of suspected cocaine following the examination of a commercial truck at the Coutts border crossing in southern Alberta.
  • During the search of the vehicle, officers also discovered 5.7 g of suspected opium.
  • The driver was subsequently arrested by the CBSA and transferred to the Alberta RCMP Integrated Border Enforcement Unit's custody along with the suspected narcotics.
  • In November 2022, CBSA officers discovered and seized a total of 96 kg of cocaine in two separate seizures (of 43 kg and 53 kg , respectively) from commercial trucks carrying produce.

HYTN Innovations expands its Controlled Drugs and Substances Dealers License to include MDMA and Ketamine

Retrieved on: 
Thursday, March 2, 2023
Psilocybin, Classification, Ground substance, Food and Drugs Act, LSD, Clinical trial, Therapeutic Goods Administration, DEL, MDMA, Cocaine, TGA, Cannabinoid, News, Prohibition of drugs, Controlled Substances Act, Food, Brazilian Controlled Drugs and Substances Act, Ketamine, CSE, Pharmaceutical industry

VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN), a Vancouver-based company specializing in the production of psychoactive and psychotropic compounds, announced today that it has submitted an amendment to its Controlled Drugs and Substances Dealers License with Health Canada.

Key Points: 
  • VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN), a Vancouver-based company specializing in the production of psychoactive and psychotropic compounds, announced today that it has submitted an amendment to its Controlled Drugs and Substances Dealers License with Health Canada.
  • The company has also entered the review stage for both a Drug Establishment License (DEL) under the Food and Drugs Act and a Precursors License under the Controlled Drugs and Substances Act.
  • HYTN is committed to maintaining a regulatory-first approach to product development and leveraging its strengths in manufacturing-controlled substances for human consumption.
  • With these developments, HYTN is well-positioned to continue its mission to provide the highest quality, regulated psychoactive and psychotropic compounds to its customers.

InvestmentPitch Media Video Discusses THC BioMed’s Launch of Sales and Exports of its Patented “Clone Shipper” Product to Asia

Retrieved on: 
Thursday, March 2, 2023
Drink, BioMed Central, Suggestion, Cannabis, FSE, Humidity, THC, News, Risk, Plant, Prohibition of drugs, Temperature, Removal of cannabis from Schedule I of the Controlled Substances Act, Brazilian Controlled Drugs and Substances Act, Hand, CSE, Drug

The video is available for viewing on “ InvestmentPitch ” and on “ YouTube ”.

Key Points: 
  • The video is available for viewing on “ InvestmentPitch ” and on “ YouTube ”.
  • If these links are not enabled, please visit www.InvestmentPitch.com and enter “THC BioMed” in the search box.
  • The virtually indestructible container is manufactured in North America and can be purchased online at www.CloneShipper.com or in Asia through THC BioMed Thailand.
  • THC BioMed has paid a fee not exceeding $2,000 in cash to have its current news release produced in video format.

HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development

Retrieved on: 
Thursday, February 23, 2023
Active ingredient, CGMP, CSE, Partnership, Health Canada, Accreditation, Controlled Substances Act, Psilocybin, Certification, API, Prohibition of drugs, Good manufacturing practice, Brazilian Controlled Drugs and Substances Act, Fine chemical

VANCOUVER, British Columbia, Feb. 23, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) announced that it has successfully initiated cultivation of psilocybin mushrooms under its Dealer’s License granted by Health Canada in accordance with the Controlled Drugs and Substances Act.

Key Points: 
  • VANCOUVER, British Columbia, Feb. 23, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) announced that it has successfully initiated cultivation of psilocybin mushrooms under its Dealer’s License granted by Health Canada in accordance with the Controlled Drugs and Substances Act.
  • This announcement is a significant development supporting HYTN's mission to be a leading manufacturer of psychoactive and psychotropic compounds.
  • "With the necessary licenses, systems, and expert personnel, HYTN is well-positioned to develop a diverse portfolio of APIs.
  • Pending cGMP accreditation, HYTN will concentrate on producing high-quality psilocybin extracts, expanding its cannabis product lines, and refining approved substances.

Statement from the Minister of Mental Health and Addictions and Associate Minister of Health on the Implementation of the subsection 56(1) Exemption from Controlled Drugs and Substances Act: Personal possession of small amounts of certain illegal substan

Retrieved on: 
Monday, January 30, 2023
Housing, Safety, Black Canadians, Controlled Substances Act, Drug, Law enforcement, Health, Toxicity, Brazilian Controlled Drugs and Substances Act, Letter, Government, Partnership, Public, Trauma, Methamphetamine, Ageing, Cocaine, Friends, MDMA, Prohibition of drugs, Investment, Property management

This crisis has, and continues to be heartbreaking for families, friends, and communities across the country.

Key Points: 
  • This crisis has, and continues to be heartbreaking for families, friends, and communities across the country.
  • Since 2016, more than 32,000 people have died of an overdose in Canada, with British Columbia severely impacted by overdose deaths and related harms.
  • On May 31, 2022, I announced the granting of a time-limited exemption under the Controlled Drugs and Substances Act for adults in the province of B.C.
  • We are very conscious of our responsibility to protect the health and safety of all people in B.C.

B.C. takes action to save lives, build new connections to care with decriminalization

Retrieved on: 
Monday, January 30, 2023
Substance, Mental health, Bed, Prohibition, Infection, Stigma, Stereotype, Canada, Provincial Health Services Authority, Brazilian Controlled Drugs and Substances Act, Government, Person, Province, Policy, Health Canada, Naloxone, Public, Police, Methamphetamine, First Nations, Ageing, Cocaine, Dutch Association of Mental Health and Addiction Care, MDMA, Prohibition of drugs, Racism, United States drug overdose death rates and totals over time, Fear, Drug, Pharmaceutical industry, Health, Addiction

's decriminalization of people who use drugs comes into effect on January 31, 2023.

Key Points: 
  • 's decriminalization of people who use drugs comes into effect on January 31, 2023.
  • will not be subject to criminal charges if they possess a small amount of certain illegal drugs for personal use.
  • Given the increasingly toxic drug supply – using alone can be fatal," said Jennifer Whiteside, Minister of Mental Health and Addictions.
  • government has been urgently working to build a comprehensive and seamless system of mental health and addictions care that works for all British Columbians.

B.C. receives exemption to decriminalize possession of some illegal drugs for personal use

Retrieved on: 
Tuesday, May 31, 2022
Government of Canada, Shame, Public health, Mental health, Fear, Leadership, Policy, Government, Mental, CDSA, Brazilian Controlled Drugs and Substances Act, Law enforcement, Adult, Police, City, Province, Federation, Social support, Drug prohibition law, Illegal drug trade, Bed, Dutch Association of Mental Health and Addiction Care, Removal of cannabis from Schedule I of the Controlled Substances Act, Columbia, Online gambling, Drug, Medical device, Addiction, Health, BC

"Eliminating criminal penalties for those carrying small amounts of illicit drugs for personal use will reduce stigma and harm and provide another tool for British Columbia to end the overdose crisis."

Key Points: 
  • "Eliminating criminal penalties for those carrying small amounts of illicit drugs for personal use will reduce stigma and harm and provide another tool for British Columbia to end the overdose crisis."
  • These substances remain illegal, but adults who have 2.5 grams or less of the certain illicit substances for personal use will no longer be arrested, charged or have their drugs seized.
  • "By decriminalizing people who use drugs, we will break down the stigma that stops people from accessing life-saving support and services."
  • "Decriminalizing possession of drugs is an historic, brave, and groundbreaking step in the fight to save lives from the poison drug crisis.

THC BioMed Sells Canada's Lowest Priced Edible in Ontario Cannabis Store

Retrieved on: 
Wednesday, February 2, 2022
Cannabis, Legislation, View, CEO, Forward-looking statement, CSE, Ontario Cannabis Retail Corporation, Drug prohibition law, BioMed Central, Brazilian Controlled Drugs and Substances Act, Company, Canadian Securities Exchange, Comments by Celebs, THC, Edible, Industry, Removal of cannabis from Schedule I of the Controlled Substances Act, Multimedia, High Expectations, Oil, Drug, BC

VANCOUVER, BC, Feb. 2, 2022 /PRNewswire/ - THC BioMed Intl Ltd. ("THC BioMed" or the "Company") announces that its THC KISS Cannabis Biscuits are now available direct to consumers through Ontario Cannabis Store online and wholesale to Ontario retail stores.

Key Points: 
  • VANCOUVER, BC, Feb. 2, 2022 /PRNewswire/ - THC BioMed Intl Ltd. ("THC BioMed" or the "Company") announces that its THC KISS Cannabis Biscuits are now available direct to consumers through Ontario Cannabis Store online and wholesale to Ontario retail stores.
  • Adding to that significant development, the THC KISS Cannabis Biscuits are the lowest priced edibles now available through the Ontario Cannabis Store.
  • This marks the launch of our THC KISS brand of full-spectrum cannabis edibles on Ontario Cannabis Store, the world's largest cannabis supplier.
  • Ontario Cannabis Store now lists 6 THC BioMed products.

THC BioMed Sells Canada's Lowest Priced Edible in Ontario Cannabis Store

Retrieved on: 
Wednesday, February 2, 2022
Cannabis, Legislation, CEO, Forward-looking statement, CSE, Ontario Cannabis Retail Corporation, Drug prohibition law, BioMed Central, Brazilian Controlled Drugs and Substances Act, Company, Canadian Securities Exchange, Comments by Celebs, THC, Edible, Industry, Removal of cannabis from Schedule I of the Controlled Substances Act, High Expectations, Oil, Drug, BC

VANCOUVER, BC, Feb. 2, 2022 /PRNewswire/ -- THC BioMed Intl Ltd. ("THC BioMed" or the "Company") announces that its THC KISS Cannabis Biscuits are now available direct to consumers through Ontario Cannabis Store online and wholesale to Ontario retail stores. Adding to that significant development, the THC KISS Cannabis Biscuits are the lowest priced edibles now available through the Ontario Cannabis Store.

Key Points: 
  • VANCOUVER, BC, Feb. 2, 2022 /PRNewswire/ -- THC BioMed Intl Ltd. ("THC BioMed" or the "Company") announces that its THC KISS Cannabis Biscuits are now available direct to consumers through Ontario Cannabis Store online and wholesale to Ontario retail stores.
  • Adding to that significant development, the THC KISS Cannabis Biscuits are the lowest priced edibles now available through the Ontario Cannabis Store.
  • This marks the launch of our THC KISS brand of full-spectrum cannabis edibles on Ontario Cannabis Store, the world's largest cannabis supplier.
  • Ontario Cannabis Store now lists 6 THC BioMed products.

THC BioMed Granted License to Cultivate Cannabis for Medical and Scientific Use

Retrieved on: 
Thursday, January 27, 2022
University, View, Natural product, THC, Apoptosis, Industry, Oregon State University, Cannabidiol, Legislation, Government, Drug prohibition law, COVID, BioMed Central, Journal of Natural Products, Canadian Securities Exchange, Edible, Multimedia, Chicago (franchise), Publication, Research, R, Removal of cannabis from Schedule I of the Controlled Substances Act, Journal, Company, Brazilian Controlled Drugs and Substances Act, COVID-19, Forbes, CSE, Review, Forward-looking statement, Drug, Medical device, Animal, Medicinal plants, Cannabis, BC, CBD

VANCOUVER, BC, Jan. 27, 2022 /PRNewswire/ - THC BioMed Intl Ltd. ("THC BioMed" or the "Company") announces that it has been granted a licence by an overseas government to cultivate cannabis for medical and scientific use.

Key Points: 
  • VANCOUVER, BC, Jan. 27, 2022 /PRNewswire/ - THC BioMed Intl Ltd. ("THC BioMed" or the "Company") announces that it has been granted a licence by an overseas government to cultivate cannabis for medical and scientific use.
  • We are in advanced discussions with the host government to conduct Scientific Research with Cannabis.
  • THC BioMedis a Cannabis Act Licensed Producer of medical and recreational cannabis.
  • The Company is on the leading edge of scientific research and the development of products and services in the medical and recreational cannabis industry.